Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-12-25
2007-12-25
Shibuya, Mark L. (Department: 1639)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C530S323000, C530S324000, C530S325000
Reexamination Certificate
active
10802080
ABSTRACT:
The present invention provides peptides and peptide analogues that mimic the structural and pharmacological properties of human ApoA-I. The peptides and peptide analogues are useful to treat a variety of disorders associated with dyslipidemia.
REFERENCES:
patent: 4229360 (1980-10-01), Schneider et al.
patent: 4411894 (1983-10-01), Schrank et al.
patent: 4643988 (1987-02-01), Segrest et al.
patent: 4857319 (1989-08-01), Crowe et al.
patent: 4880635 (1989-11-01), Janoff et al.
patent: 5089602 (1992-02-01), Isliker et al.
patent: 6004925 (1999-12-01), Dasseux et al.
patent: 6037323 (2000-03-01), Dasseux et al.
patent: 6046166 (2000-04-01), Dasseux et al.
patent: 6265377 (2001-07-01), Dasseux et al.
patent: 6329341 (2001-12-01), Dasseux et al.
patent: 6376464 (2002-04-01), Dasseux et al.
patent: 6518412 (2003-02-01), Dasseux et al.
patent: 6573239 (2003-06-01), Dasseux et al.
patent: 6602854 (2003-08-01), Dasseux et al.
patent: 6630450 (2003-10-01), Dasseux et al.
patent: 6716816 (2004-04-01), Dasseux et al.
patent: 6734169 (2004-05-01), Dasseux et al.
patent: 6753313 (2004-06-01), Dasseux et al.
patent: 2003/0008827 (2003-01-01), Dasseux et al.
patent: 2003/0060604 (2003-03-01), Dasseux et al.
patent: 2003/0203842 (2003-10-01), Dasseux et al.
patent: 2003/0208059 (2003-11-01), Dasseux et al.
patent: 2004/0029807 (2004-02-01), Dasseux et al.
patent: 2004/0198662 (2004-10-01), Dasseux et al.
patent: 2005/0080013 (2005-04-01), Dasseux et al.
patent: 0 162 414 (1985-05-01), None
patent: WO93/25581 (1993-12-01), None
patent: WO94/04177 (1994-03-01), None
patent: WO94/13819 (1994-06-01), None
patent: WO96/04916 (1996-02-01), None
patent: WO96/05227 (1996-02-01), None
patent: WO96/37608 (1996-11-01), None
patent: WO 97/36927 (1997-10-01), None
patent: WO 97/43311 (1997-11-01), None
patent: WO99/16459 (1998-09-01), None
Anantharamaiah, 1986,Methods in Enzymology 128:627-647.
Anantharamaiah et al., 1985,J. Biol. Chem. 260:10248-10255.
Anantharamaiah et al., 1986,Proteins of Biological Fluids 34:63-66.
Anantharamaiah et al., 1990,Arteriosclerosis 10(1):95-105.
Anantharamaiah et al., 1991,Adv. Exp. Med. Biol. 285:131-140.
Badimon et al., 1990,J. Clin. Invest. 85:1234-1241.
Barrans et al., 1996,Biochim. Biophys. Acta 1300:73-85.
Beitz et al., 1992,Prostaglandins, Leukotrienes and Essential Fatty Acids 47:149-152.
Berard et al., 1997,Nature Medicine 3(7):744-749.
Blondelle et al., 1993,Biochim. Biophys. Acta 1202:331-336.
Brasseur, 1991,J. Biol. Chem. 266(24):16120-16127.
Brasseur et al., 1990,Biochim. Biophys. Acta 1043:245-252.
Brasseur et al., 1993,Biochim. Biophys. Acta 1170:1-7.
Brouilette and Anantharamaiah, 1995,Biochim. Biophys. Acta 1256:103-129.
Burkey et al., 1992,Circulation, Supplement I 86:1-472, Abstract No. 1876.
Burkey et al., 1995,J. Lipid Res. 36:1463-1473.
Cheung et al., 1991 ,Lipid Res. 32:383-394.
Chung et al., 1985,J. Biol. Chem. 260:10256-10262.
Collet et al., 1997,Journal of Lipid Research 38:634-644.
Corijn et al., 1993,Biochim. Biophys. Acta 1170:8-16.
Cornut et al., 1994 “The Amphipathic α-Helix Concept, Application to the De Novo Design of Ideally Amphipathic Leu, Lys Peptides With Hemolytic Activity Higher Than That of Melittin,”FEBS Letters, 349:29-33.
Cox et al.,The Interaction of Calmodulin with Amphipathic Peptides J. Biol. Chem. 260(4):2527-2534.
Davidson et al., 1994,J. Biol. Chem. 269(37):22975-22982.
Davidson et al., 1996,Proc. Natl. Acad. Sci. U.S.A. 93:13605-13610.
Deamer et al., 1983,Liposomes(Ostro, Ed.), Marcel Dekker, Inc., New York.
Demoor et al., 1996,24th European Chemical Peptide Symposium.
Demoor et al., 1996,Eur. J. Biochem. 239:74-84.
Dufourcq et al., 1986,Biochim. Biophys. Acta 859:33-48.
Duverger, 1996,Circulation 94:713-717.
Duverger et al., 1996,Arterioscler. Thromb. Vasc. Biol. 16:1424-1429.
Emmanuel et al., 1994,J. Biol. Chem. 269(47):29883-29890.
Epand et al., 1987,J. Biol. Chem. 262:9389-9396.
Epand et al., 1995,Biopolymers(Peptide Science)37:319-338.
Esposito et al., 1997,Biopolymers 41:27-35.
Fielding and Fielding, 1995,J. Lipid Res. 36:211-228.
Fournier et al., 1996,J. Lipid Res. 37:1704-1711.
Francone et al., 1995,J. Clinic. Invet. 96:1440-1448.
Frank et al., 1997,Biochemistry 36:1789-1806.
Fruchart and Ailhaud, 1992,Clin. Chem. 38:793-797.
Fukushima et al., 1979,J. Am. Chem. Soc. 101(13):3703-3704.
Fukushima et al., 1980,J. Biol. Chem. 255:10651-10657.
Garber et al., 1992,Arteriosclerosis and Thrombosis 12:886-894.
Gordon et al., 1989,Circulation 79:8-15.
Gordon and Rifkind, 1989,N. Eng. J. Med. 321:1311-1316.
Groebke et al., 1996,Proc. Natl. Acad. Sci. U.S.A. 93:4025-4029.
Hirano et al., 1997,Arterioscler. Thromb. Vasc. Biol. 17(6):1053-1059.
Holvoet et al., 1995,Biochemistry 34:13334-13342.
Hope et al., 1986,Chemistry and Physics of Lipids 40:89-107.
Huyghues-Despointes et al., 1995,Biochemistry 34(41):13267-13271.
Ji and Jonas, 1995,J. Biol. Chem. 270:11290-11297.
Johnson et al., 1971,Biochim. Biophys. Acta 233:820.
Jonas, 1986,Methods in Enzymol. 128:553-582.
Jonas, 1992, “Lipid-Binding Properties of Apolipoproteins,”In: Structure and Function of Apolipoproteins, CRC Press, Ch. 8, pp. 217-250.
Kaiser, 1970,Anal. Biochem. 34:595-598.
Kaiser and Kezdy, 1983,Proc. Natl. Acad. Sci. U.S.A. 80:1137-1143.
Kannelis et al., 1980,J. Biol. Chem. 255(3):11464-11472.
Koizumi et al., 1988,J. Lipid Res. 29:1405-1415.
Kneib-Cordonnier et al., 1990,Int. J. Peptide Protein Res. 35:527-538.
Knott et al., 1985,Science 230:37-43.
Labeur et al., 1997,Arterioscler. Throm. Vasc. Biol. 17:580-588.
Lacko and Miller, 1997,J. Lip. Res. 38:1267-1273.
Li et al., 1996,Proc. Natl. Acad. Sci. U.S.A. 93:6676-6681.
Lins et al., 1993,Biochim. Biophys. Acta Biomembranes 1151:137-142.
Liu et al., 1994,J. Lipid Res. 35:2263-2267.
Livingstone, 1974,Methods in Enzymology: Immunoaffinity Chromatography of Proteins 34:723-731.
Lund-Katz et al., 1990,J. Biol. Chem. 265(21):12217-12223.
Lund-Katz et al., 1995,Biochemistry 34:9219-9226.
Marqusee et al., 1987,Proc. Natl. Acad. Sci. U.S.A. 84(24):8898-8902.
Mendez et al., 1994,J. Clin. Invest. 94:1698-1705.
Mezdour et al., 1995,Atherosclerosis 113:237-246.
Miller, 1987,Amer. Heart 113:589-597.
Milner-White and Poet, 1987,Trends Biochem. Sci. 12:189-192.
Minnich et al., 1992,J. Biol. Chem. 267:16553-16560.
Mishra et al., 1994,J. Biol. Chem. 269(10):7185-7191.
Mishra et al., 1995,J. Biol. Chem. 270(4):1602-1611.
Nakagawa et al., 1985,J. Am. Chem. Soc. 107:7087-7092.
Nedelec et al., 1989,Biochimie 71:145-151.
Palgunachari et al., 1996,Arterioscler. Thromb. Vasc. Biol. 16:328-338.
Paszty et al., 1994,J. Clin. Invest. 94:899-903.
Plump et al., 1994,Proc. Natl. Acad. Sci. U.S.A. 91:9607-9611.
Ponsin et al., 1984,Biochemistry 23:5337-5342.
Ponsin et al., 1986,J. Biol. Chem. 261(20):9202-9205.
Pownall et al., 1980,Proc. Natl. Acad. Sci. U.S.A. 77(6):3154-3158.
Rogers et al., 1997,Biochemistry 36:288-300.
Rosseneu et al.,In: Structure and Function of the Lipoproteins, Ch. 6, 159-183, CRC Press, Inc., 1992.
Rosseneu and Labeur, 1995,FASEB J. 9:768-776.
Rubin et al., 1991,Nature 353:265-267.
Schnölzer and Kent, 1992,Science 256:221-225.
Schultz et al., 1993,Nature 365:762-764.
Segrest, 1974,FEBS Lett. 38:247-253.
Segrest, 1976,FEBS Lett. 69(1):111-114.
Segrest et al., 1983,J. Biol. Chem. 258:2290-2295.
Segrest et al., 1990,PROTEINS: Structure, Function and Genetics 8:103-117.
Segrest et al., 1992,J. Lipid Res. 33:141-166.
Segrest et al., 1994,Advances in Protein Chemistry 45:303-369.
Sorci-Thomas et al., 1993,J. Biol. Chem. 268:21403-21409.
Sorci-Thomas et al., 1997,J. Biol. Chem. 272(11):7278-7284.
Sparks et al., 1995,J. Biol. Chem. 270(10):5151-5157.
Sparrow and Gotto, 1980,Ann. N.Y. Acad. Sci. 348:187-211.
Sparrow and Gotto, 1982,CRC Crit. Rev. Biochem. 13:87-107.
Sparrow and Gotto, Ch. 10: “Lipid-Protein Interactions: Structure-Function Relationships”.
Sparrow et al., 1981,In: “Peptides: Synthesis-Structure-Function,” Roch and Gross, Eds., Pierce Chem. Co., Rockford, IL, 253-256.
Spatola, Arno F., 1983 “Peptide Backbone Modifications: Astructure-Activity A
Büttner Klaus
Cornut Isabelle
Dasseux Jean-Louis
Dufourcq Jean
Metz Günther
Benson Gregg C.
Shibuya Mark L.
Slepchuk, Jr. Nicholas I.
LandOfFree
Pharmaceutical compositions of apolipoprotein A-I agonists... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions of apolipoprotein A-I agonists..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions of apolipoprotein A-I agonists... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3886375